Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PF Consumer Healthcare, formerly the consumer division of Pfizer, is a global leader in over-the-counter (OTC) medicines, vitamins, and wellness products. The company's portfolio includes iconic brands such as Advil, Centrum, Robitussin, and Emergen-C. In 2019, Pfizer combined this business with GlaxoSmithKline's consumer healthcare unit to create a premier joint venture. This entity was subsequently spun off in July 2022 to form Haleon, an independent, publicly traded company. Today, the legacy PF Consumer Healthcare assets operate under the Haleon umbrella, focusing on categories like pain relief, respiratory health, and wellness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PF Consumer Healthcare.